EPISODE · Jul 22, 2022 · 9 MIN
Tolebrutinib Trials Paused Over Safety Concerns & Setback for MS Spasticity Treatment
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new U.S. enrollments in Phase 3 trials of tolebrutinib for MS have been paused due to some reports of liver injury.He also reads “Trial Results a Setback for US Approval of Nabiximols for MS Spasticity” from Ed Tobias’ column “The MS Wire.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
Tolebrutinib Trials Paused Over Safety Concerns & Setback for MS Spasticity Treatment
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m